Elite Pharmaceuticals (ELTP) Income After Tax (2009 - 2026)
Elite Pharmaceuticals' Income After Tax came in at $17.32 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 26.4% from $13.7 million a year earlier and up 193.0% from the prior quarter.
Elite Pharmaceuticals (ELTP) Income After Tax (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Elite Pharmaceuticals reported Income After Tax of $60.28 million, up 335.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $44.87 million.
- Going back by fiscal year, Income After Tax was -$4.4 million in FY2025, $20.15 million in FY2024 (+465.6%), $3.56 million in FY2023 (-55.7%) and $8.04 million in FY2022.
- The five-year range for quarterly Income After Tax is -$11.04 million (fiscal Q2 2025) to $18.59 million (fiscal Q3 2026).
- The fastest year-over-year change in Income After Tax over five years came in fiscal Q2 2024 (growth of 885.7%), and the weakest in fiscal Q1 2023 (a decline of 80.1%).
- Business Quant data shows ELTP's Income After Tax at $5.91 million (Q1 2027), $18.46 million (Q4 2026) and $18.59 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 17.32 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17.32 Mn |
| Jun 30, 2026 | 5.91 Mn |
| Mar 31, 2026 | 18.46 Mn |
| Dec 31, 2025 | 18.59 Mn |
| Sep 30, 2025 | 13.70 Mn |
| Jun 30, 2025 | -5.88 Mn |
| Mar 31, 2025 | 16.91 Mn |
| Dec 31, 2024 | -10.89 Mn |
| Sep 30, 2024 | -11.04 Mn |
| Jun 30, 2024 | 615,773.00 |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 706,354.00 |
| Sep 30, 2023 | 14.93 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | -1.23 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 305,883.00 |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 2.28 Mn |
Elite Pharmaceuticals Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();